GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (BSP:C1CO34) » Definitions » Stock Based Compensation

Cencora (BSP:C1CO34) Stock Based Compensation : R$672 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cencora Stock Based Compensation?

Cencora's Stock Based Compensation for the three months ended in Mar. 2024 was R$140 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was R$672 Mil.


Cencora Stock Based Compensation Historical Data

The historical data trend for Cencora's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Stock Based Compensation Chart

Cencora Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 242.52 401.81 525.74 489.75 615.46

Cencora Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.40 99.84 123.12 309.08 140.23

Cencora Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$672 Mil.


Cencora Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Cencora's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora (BSP:C1CO34) Business Description

Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (BSP:C1CO34) Headlines

No Headlines